A detailed history of Cibc Private Wealth Group, LLC transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 2,509 shares of PACB stock, worth $4,440. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,509
Previous 1,734 44.69%
Holding current value
$4,440
Previous $2,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$1.2 - $2.17 $930 - $1,681
775 Added 44.69%
2,509 $4,000
Q2 2024

Aug 09, 2024

BUY
$1.36 - $3.65 $340 - $912
250 Added 16.85%
1,734 $2,000
Q1 2024

May 10, 2024

BUY
$3.52 - $9.59 $5,223 - $14,231
1,484 New
1,484 $5,000

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $398M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track This Portfolio

Track Cibc Private Wealth Group, LLC Portfolio

Follow Cibc Private Wealth Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc Private Wealth Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cibc Private Wealth Group, LLC with notifications on news.